cGMP Manufacturing Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology  

 2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on CGMP Manufacturing Market 

5.1. COVID-19 Landscape: CGMP Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global CGMP Manufacturing Market, By Product Type

8.1. CGMP Manufacturing Market Revenue and Volume, by Product Type

8.1.1. Small Molecules

8.1.1.1. Market Revenue and Volume Forecast  

8.1.2. Biologics

8.1.2.1. Market Revenue and Volume Forecast  

8.1.3. Cell & Gene Therapies

8.1.3.1. Market Revenue and Volume Forecast  

8.1.4. Vaccines

8.1.4.1. Market Revenue and Volume Forecast  

Chapter 9. Global CGMP Manufacturing Market, By Process Type

9.1. CGMP Manufacturing Market Revenue and Volume, by Process Type

9.1.1. Upstream Processing

9.1.1.1. Market Revenue and Volume Forecast  

9.1.2. Downstream Processing

9.1.2.1. Market Revenue and Volume Forecast  

9.1.3. Fill-Finish/Final Packaging

9.1.3.1. Market Revenue and Volume Forecast  

Chapter 10. Global CGMP Manufacturing Market, By Scale of Operation

10.1. CGMP Manufacturing Market Revenue and Volume, by Scale of Operation

10.1.1. Preclinical

10.1.1.1. Market Revenue and Volume Forecast  

10.1.2. Clinical (Phase I–III)

10.1.2.1. Market Revenue and Volume Forecast  

10.1.3. Commercial

10.1.3.1. Market Revenue and Volume Forecast  

Chapter 11. Global CGMP Manufacturing Market, By Service Type

11.1. CGMP Manufacturing Market Revenue and Volume, by Service Type

11.1.1. Manufacturing Services

11.1.1.1. Market Revenue and Volume Forecast  

11.1.2. Analytical & Quality Control Services

11.1.2.1. Market Revenue and Volume Forecast  

11.1.3. Packaging & Fill-Finish Services

11.1.3.1. Market Revenue and Volume Forecast  

11.1.4. Technology Transfer & Scale-Up

11.1.4.1. Market Revenue and Volume Forecast  

Chapter 12. Global CGMP Manufacturing Market, By Therapeutic Area

12.1. CGMP Manufacturing Market Revenue and Volume, by Therapeutic Area

12.1.1. Oncology

12.1.1.1. Market Revenue and Volume Forecast  

12.1.2. Immunology

12.1.2.1. Market Revenue and Volume Forecast  

12.1.2. Rare Diseases

12.1.2.1. Market Revenue and Volume Forecast  

12.1.2. Infectious Diseases

12.1.2.1. Market Revenue and Volume Forecast  

Chapter 13. Global CGMP Manufacturing Market, By End-User

13.1. CGMP Manufacturing Market Revenue and Volume, by End-User

13.1.1. Pharmaceutical & Biotechnology Companies

13.1.1.1. Market Revenue and Volume Forecast  

13.1.2. CDMOs / CMOs

13.1.2.1. Market Revenue and Volume Forecast  

13.1.3. Research Institutes

13.1.3.1. Market Revenue and Volume Forecast  

Chapter 14. Global CGMP Manufacturing Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Product Type  

14.1.2. Market Revenue and Volume Forecast, by Process Type  

14.1.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.1.4. Market Revenue and Volume Forecast, by Service Type  

14.1.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.1.6. Market Revenue and Volume Forecast, by End-User  

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Product Type  

14.1.7.2. Market Revenue and Volume Forecast, by Process Type  

14.1.7.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.1.7.4. Market Revenue and Volume Forecast, by Service Type  

14.1.8. Market Revenue and Volume Forecast, by Therapeutic Area  

14.1.8.1. Market Revenue and Volume Forecast, by End-User   

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Product Type  

14.1.9.2. Market Revenue and Volume Forecast, by Process Type  

14.1.9.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.1.9.4. Market Revenue and Volume Forecast, by Service Type  

14.1.10. Market Revenue and Volume Forecast, by Therapeutic Area  

14.1.11. Market Revenue and Volume Forecast, by End-User  

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Product Type  

14.2.2. Market Revenue and Volume Forecast, by Process Type  

14.2.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.2.4. Market Revenue and Volume Forecast, by Service Type   

14.2.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.2.6. Market Revenue and Volume Forecast, by End-User  

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Product Type  

14.2.8.2. Market Revenue and Volume Forecast, by Process Type  

14.2.8.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.2.9. Market Revenue and Volume Forecast, by Service Type   

14.2.10. Market Revenue and Volume Forecast, by Therapeutic Area  

14.2.10.1. Market Revenue and Volume Forecast, by End-User   

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Product Type  

14.2.11.2. Market Revenue and Volume Forecast, by Process Type  

14.2.11.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.2.12. Market Revenue and Volume Forecast, by Service Type  

14.2.13. Market Revenue and Volume Forecast, by Therapeutic Area  

14.2.14. Market Revenue and Volume Forecast, by End-User  

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Product Type  

14.2.15.2. Market Revenue and Volume Forecast, by Process Type  

14.2.15.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.2.15.4. Market Revenue and Volume Forecast, by Service Type  

14.2.16. Market Revenue and Volume Forecast, by Therapeutic Area  

14.2.16.1. Market Revenue and Volume Forecast, by End-User  

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Product Type  

14.2.17.2. Market Revenue and Volume Forecast, by Process Type  

14.2.17.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.2.17.4. Market Revenue and Volume Forecast, by Service Type  

14.2.18. Market Revenue and Volume Forecast, by Therapeutic Area  

14.2.18.1. Market Revenue and Volume Forecast, by End-User  

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Product Type  

14.3.2. Market Revenue and Volume Forecast, by Process Type  

14.3.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.3.4. Market Revenue and Volume Forecast, by Service Type  

14.3.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.3.6. Market Revenue and Volume Forecast, by End-User  

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Product Type  

14.3.7.2. Market Revenue and Volume Forecast, by Process Type  

14.3.7.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.3.7.4. Market Revenue and Volume Forecast, by Service Type  

14.3.8. Market Revenue and Volume Forecast, by Therapeutic Area  

14.3.9. Market Revenue and Volume Forecast, by End-User  

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Product Type  

14.3.10.2. Market Revenue and Volume Forecast, by Process Type  

14.3.10.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.3.10.4. Market Revenue and Volume Forecast, by Service Type  

14.3.11. Market Revenue and Volume Forecast, by Therapeutic Area  

14.3.11.1. Market Revenue and Volume Forecast, by End-User  

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Product Type  

14.3.12.2. Market Revenue and Volume Forecast, by Process Type  

14.3.12.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.3.12.4. Market Revenue and Volume Forecast, by Service Type  

14.3.12.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.3.12.6. Market Revenue and Volume Forecast, by End-User  

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Product Type  

14.3.13.2. Market Revenue and Volume Forecast, by Process Type  

14.3.13.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.3.13.4. Market Revenue and Volume Forecast, by Service Type  

14.3.13.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.3.13.6. Market Revenue and Volume Forecast, by End-User  

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Product Type  

14.4.2. Market Revenue and Volume Forecast, by Process Type  

14.4.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.4.4. Market Revenue and Volume Forecast, by Service Type  

14.4.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.4.6. Market Revenue and Volume Forecast, by End-User  

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Product Type  

14.4.7.2. Market Revenue and Volume Forecast, by Process Type  

14.4.7.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.4.7.4. Market Revenue and Volume Forecast, by Service Type  

14.4.8. Market Revenue and Volume Forecast, by Therapeutic Area  

14.4.9. Market Revenue and Volume Forecast, by End-User  

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Product Type  

14.4.10.2. Market Revenue and Volume Forecast, by Process Type  

14.4.10.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.4.10.4. Market Revenue and Volume Forecast, by Service Type  

14.4.11. Market Revenue and Volume Forecast, by Therapeutic Area  

14.4.12. Market Revenue and Volume Forecast, by End-User  

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Product Type  

14.4.13.2. Market Revenue and Volume Forecast, by Process Type  

14.4.13.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.4.13.4. Market Revenue and Volume Forecast, by Service Type  

14.4.13.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.4.13.6. Market Revenue and Volume Forecast, by End-User  

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Product Type  

14.4.14.2. Market Revenue and Volume Forecast, by Process Type  

14.4.14.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.4.14.4. Market Revenue and Volume Forecast, by Service Type  

14.4.14.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.4.14.6. Market Revenue and Volume Forecast, by End-User  

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Product Type  

14.5.2. Market Revenue and Volume Forecast, by Process Type  

14.5.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.5.4. Market Revenue and Volume Forecast, by Service Type  

14.5.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.5.6. Market Revenue and Volume Forecast, by End-User  

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Product Type  

14.5.7.2. Market Revenue and Volume Forecast, by Process Type  

14.5.7.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.5.7.4. Market Revenue and Volume Forecast, by Service Type  

14.5.8. Market Revenue and Volume Forecast, by Therapeutic Area  

14.5.8.1. Market Revenue and Volume Forecast, by End-User  

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Product Type  

14.5.9.2. Market Revenue and Volume Forecast, by Process Type  

14.5.9.3. Market Revenue and Volume Forecast, by Scale of Operation  

14.5.9.4. Market Revenue and Volume Forecast, by Service Type  

14.5.9.5. Market Revenue and Volume Forecast, by Therapeutic Area  

14.5.9.6. Market Revenue and Volume Forecast, by End-User  

Chapter 15. Company Profiles

15.1. Lonza Group

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Thermo Fisher Scientific

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Catalent Pharma Solutions

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Samsung Biologics

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Fujifilm Diosynth Biotechnologies

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Boehringer Ingelheim BioXcellence

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. WuXi AppTec/WuXi Biologics

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. AbbVie Contract Manufacturing

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. AGC Biologics

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Novartis Gene Therapies

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms